Weill Cornell's Mateo Mejia Saldarriaga, MD, discusses patient preference for on-body isatuximab and how to sequence CAR T and bispecifics in myeloma.
Mateo Mejia Saldarriaga, MD
Advertisement
Articles by Mateo Mejia Saldarriaga, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
2
MASH Fibrosis, Not Resolution, Predicts Mortality: Zobair Younossi, MD
3
A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD
4
Using Complement Inhibitors in GA Comes With Pros and Cons
5